Skip to content

RNTX RNTX Total Operating Expenses

Total Operating Expenses at other companies

CTO
Citius Oncology, Inc.CTOR
$29.95M+301%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$11.44M-27.5%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$99.07M-4.6%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$76.67M+42.9%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's total operating expenses?
RNTX (RNTX) reported total operating expenses of $5.23M in Q1 2026.
How has RNTX's total operating expenses changed year-over-year?
RNTX's total operating expenses decreased by 6.8% year-over-year, from $5.61M to $5.23M.
What is the long-term trend for RNTX's total operating expenses?
Over 4 years (2021 to 2025), RNTX's total operating expenses has grown at a 17.5% compound annual growth rate (CAGR), from $26.61M to $50.63M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.